Moolec Science SA (NASDAQ:MLECW) Sees Significant Decrease in Short Interest

Moolec Science SA (NASDAQ:MLECW) saw a significant decrease in short interest in the month of June. As of June 30th, there was short interest totaling 129 shares, a decrease of 98.9% from the June 15th total of 12,167 shares. Based on an average daily trading volume, of 32,376 shares, the short-interest ratio is currently 0.0 days.

Moolec Science Price Performance

Shares of MLECW traded up $0.00 during mid-day trading on Friday, reaching $0.02. 15,077 shares of the company were exchanged, compared to its average volume of 560,220. The business has a 50 day simple moving average of $0.02 and a two-hundred day simple moving average of $0.02. Moolec Science has a 52 week low of $0.00 and a 52 week high of $0.16.

Moolec Science Company Profile

Moolec Science is a biotechnology company focused on developing gene-edited livestock as living bioreactors to produce therapeutic proteins. The company leverages CRISPR/Cas9 and related gene-editing technologies to introduce human genes into the genome of pigs, enabling the secretion of complex human proteins in sow’s milk. By combining advanced genetic engineering with traditional livestock breeding, Moolec Science aims to address scalability and cost challenges associated with conventional biologics manufacturing.

The company’s pipeline centers on the production of large multimolecular proteins, including coagulation factors and antibody fragments, for rare diseases and life-threatening conditions.